PMC:7205724 / 33-182 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":99,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":56,"end":80},"obj":"Chemical"},{"id":"T2","span":{"begin":120,"end":135},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_35705"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":99,"end":114},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T1","span":{"begin":56,"end":73},"obj":"http://purl.obolibrary.org/obo/IDO_0000610"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T1","span":{"begin":120,"end":135},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T2","span":{"begin":7,"end":81},"obj":"Sentence"},{"id":"T3","span":{"begin":82,"end":135},"obj":"Sentence"},{"id":"T4","span":{"begin":137,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T5","span":{"begin":5,"end":6},"obj":"-COLON-"},{"id":"T6","span":{"begin":7,"end":16},"obj":"NN"},{"id":"T7","span":{"begin":17,"end":20},"obj":"CC"},{"id":"T8","span":{"begin":21,"end":31},"obj":"NN"},{"id":"T9","span":{"begin":32,"end":35},"obj":"IN"},{"id":"T10","span":{"begin":36,"end":39},"obj":"DT"},{"id":"T11","span":{"begin":40,"end":43},"obj":"NN"},{"id":"T12","span":{"begin":44,"end":46},"obj":"IN"},{"id":"T13","span":{"begin":47,"end":55},"obj":"JJ"},{"id":"T14","span":{"begin":56,"end":73},"obj":"JJ"},{"id":"T15","span":{"begin":74,"end":80},"obj":"NNS"},{"id":"T16","span":{"begin":80,"end":81},"obj":"-COLON-"},{"id":"T17","span":{"begin":82,"end":97},"obj":"NNS"},{"id":"T18","span":{"begin":97,"end":98},"obj":"-COMMA-"},{"id":"T19","span":{"begin":99,"end":114},"obj":"NNS"},{"id":"T20","span":{"begin":114,"end":115},"obj":"-COMMA-"},{"id":"T21","span":{"begin":116,"end":119},"obj":"CC"},{"id":"T22","span":{"begin":120,"end":135},"obj":"NNS"},{"id":"T23","span":{"begin":137,"end":147},"obj":"NNS"},{"id":"T24","span":{"begin":148,"end":149},"obj":"IN"}],"relations":[{"id":"R5","pred":"arg1Of","subj":"T6","obj":"T7"},{"id":"R6","pred":"arg2Of","subj":"T8","obj":"T7"},{"id":"R7","pred":"arg1Of","subj":"T7","obj":"T9"},{"id":"R8","pred":"arg2Of","subj":"T11","obj":"T9"},{"id":"R9","pred":"arg1Of","subj":"T11","obj":"T10"},{"id":"R10","pred":"arg1Of","subj":"T11","obj":"T12"},{"id":"R11","pred":"arg2Of","subj":"T15","obj":"T12"},{"id":"R12","pred":"arg1Of","subj":"T15","obj":"T13"},{"id":"R13","pred":"arg1Of","subj":"T15","obj":"T14"},{"id":"R14","pred":"arg1Of","subj":"T7","obj":"T16"},{"id":"R15","pred":"arg1Of","subj":"T17","obj":"T18"},{"id":"R16","pred":"arg2Of","subj":"T19","obj":"T18"},{"id":"R17","pred":"arg1Of","subj":"T21","obj":"T20"},{"id":"R18","pred":"arg1Of","subj":"T18","obj":"T21"},{"id":"R19","pred":"arg2Of","subj":"T22","obj":"T21"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":99,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":7,"end":81},"obj":"Sentence"},{"id":"T3","span":{"begin":82,"end":135},"obj":"Sentence"},{"id":"T4","span":{"begin":137,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n•"}